| Health / Medical Topics |
GW786034
A drug used to treat advanced renal cell carcinoma, which is the most common type of kidney cancer. It is also used to treat advanced soft tissue sarcoma that has been treated with other anticancer drugs. It is being studied in the treatment of other types of cancer. GW786034 may prevent the growth of new blood vessels that tumors need to grow. It is a type of protein tyrosine kinase inhibitor and a type of antiangiogenesis agent. Also called pazopanib hydrochloride and Votrient. (NCI Dictionary)
YOU MAY ALSO LIKE
A tablet formulation containing 5-ethynyluracil (GW776), an ethynyl derivative of uracil and the antineoplastic agent 5-Fluorouracil (5-FU) in a 10:1 ratio. …
A drug used with another anticancer drug to treat breast cancer that is HER2 positive and has advanced or metastasized (spread to…
A disease caused when cells from a donated stem cell graft attack the normal tissue of the transplant patient. Symptoms include jaundice,…
A whole cell vaccine expressing human granulocyte macrophage-colony stimulating factor (GM-CSF) with potential antineoplastic activity. Tumor cells from prostate cancer patients are…
An irradiated, autologous pancreatic cancer vaccine consisting of patient-specific pancreatic cancer cells genetically modified to secrete the cytokine granulocyte-macrophage colony stimulating factor…
An autologous lung cancer vaccine consisting of patient-specific lung cancer cells genetically modified to secrete granulocyte-macrophage colony stimulating factor (GM-CSF), an immunostimulatory…
